HB Wealth Management LLC bought a new position in shares of National Vision Holdings, Inc. (NASDAQ:EYE – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 32,475 shares of the company’s stock, valued at approximately $948,000.
Several other institutional investors have also added to or reduced their stakes in the company. Geneos Wealth Management Inc. bought a new stake in shares of National Vision in the third quarter valued at about $29,000. Elevation Point Wealth Partners LLC acquired a new position in shares of National Vision during the 2nd quarter worth $35,000. IFP Advisors Inc bought a new position in shares of National Vision in the second quarter worth about $83,000. Canada Pension Plan Investment Board lifted its stake in National Vision by 333.3% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,900 shares of the company’s stock valued at $90,000 after purchasing an additional 3,000 shares during the last quarter. Finally, USA Financial Formulas acquired a new stake in shares of National Vision during the 2nd quarter valued at $128,000.
Analyst Ratings Changes
A number of equities research analysts have weighed in on EYE shares. Weiss Ratings reissued a “sell (d-)” rating on shares of National Vision in a report on Wednesday, October 8th. Citigroup lifted their target price on National Vision from $29.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, November 18th. Barclays upped their price objective on shares of National Vision from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Tuesday, November 18th. Guggenheim upgraded National Vision to a “strong-buy” rating in a report on Wednesday, December 10th. Finally, Wall Street Zen cut shares of National Vision from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.58.
National Vision Price Performance
EYE opened at $27.42 on Tuesday. The firm has a 50-day moving average of $26.95 and a 200 day moving average of $25.74. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.32 and a current ratio of 0.53. National Vision Holdings, Inc. has a fifty-two week low of $10.15 and a fifty-two week high of $29.87. The firm has a market cap of $2.17 billion, a P/E ratio of -913.70, a PEG ratio of 1.58 and a beta of 1.38.
National Vision (NASDAQ:EYE – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of $0.12 by $0.01. National Vision had a positive return on equity of 3.58% and a negative net margin of 0.12%.The business had revenue of $487.33 million for the quarter, compared to the consensus estimate of $472.98 million. During the same quarter in the prior year, the business earned $0.12 earnings per share. National Vision’s revenue for the quarter was up 7.9% on a year-over-year basis. National Vision has set its FY 2025 guidance at 0.620-0.700 EPS. On average, research analysts expect that National Vision Holdings, Inc. will post 0.31 EPS for the current year.
National Vision Company Profile
National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.
Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.
Recommended Stories
- Five stocks we like better than National Vision
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Want to see what other hedge funds are holding EYE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Vision Holdings, Inc. (NASDAQ:EYE – Free Report).
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.
